gatifloxacin has been researched along with Fasting Hypoglycemia in 33 studies
Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.
Fasting Hypoglycemia: HYPOGLYCEMIA expressed in the postabsorptive state, after prolonged FASTING, or an overnight fast.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gatifloxacin, a fluoroquinolone antimicrobial agent, has been reported to cause both hypoglycemia and hyperglycemia in diabetic and non-diabetic patients." | 7.76 | Gatifloxacin-induced histamine release and hyperglycemia in rats. ( Ishiwata, Y; Yasuhara, M, 2010) |
| "To compare rates of hypoglycemia and hyperglycemia among elderly hospitalized patients with normal blood glucose concentrations at baseline who were receiving either gatifloxacin or levofloxacin, and to determine if appropriateness of their doses, according to their package inserts, was associated with hypoglycemia or hyperglycemia." | 7.74 | Effects of gatifloxacin and levofloxacin on rates of hypoglycemia and hyperglycemia among elderly hospitalized patients. ( Graves, J; Lodise, T; Lomaestro, B; Miller, C; Mohr, JF; Smith, RP, 2007) |
| "Gatifloxacin, until recently one of the most commonly prescribed antibiotics, has been shown to produce hypoglycemia." | 7.74 | Gatifloxacin produces both hypoglycemia and hyperglycemia: a retrospective study. ( Brown, R; Haerian, H; McHugh, P; Solomon, SS; Somes, G, 2008) |
| "We present the histories, clinical findings, and hospital course of three patients who developed hypoglycemia after receiving gatifloxacin." | 7.73 | Hypoglycemia associated with the use of gatifloxacin. ( Arce, FC; Bhasin, R; Pasmantier, R, 2005) |
| "A case of Gatifloxacin-induced severe and recurrent hypoglycemia in 62-year-old type 2 diabetic patient is presented." | 7.73 | Gatifloxacin-induced severe hypoglycemia in a patient with type 2 diabetes mellitus. ( Talwalkar, PG, 2006) |
| "Severe and resistant hypoglycemia occurred in two patients with diabetes mellitus who were receiving concomitant gatifloxacin and glyburide." | 7.72 | Severe and resistant hypoglycemia associated with concomitant gatifloxacin and glyburide therapy. ( Bélanger, C; Cossette, P; LeBlanc, M, 2004) |
| "To report a case of hypoglycemia in a patient receiving gatifloxacin for presumed exacerbation of chronic obstructive pulmonary disease (COPD)." | 7.71 | Possible gatifloxacin-induced hypoglycemia. ( Baker, SE; Hangii, MC, 2002) |
| "Gatifloxacin, a fluoroquinolone antimicrobial agent, has been reported to cause both hypoglycemia and hyperglycemia in diabetic and non-diabetic patients." | 3.76 | Gatifloxacin-induced histamine release and hyperglycemia in rats. ( Ishiwata, Y; Yasuhara, M, 2010) |
| "To compare rates of hypoglycemia and hyperglycemia among elderly hospitalized patients with normal blood glucose concentrations at baseline who were receiving either gatifloxacin or levofloxacin, and to determine if appropriateness of their doses, according to their package inserts, was associated with hypoglycemia or hyperglycemia." | 3.74 | Effects of gatifloxacin and levofloxacin on rates of hypoglycemia and hyperglycemia among elderly hospitalized patients. ( Graves, J; Lodise, T; Lomaestro, B; Miller, C; Mohr, JF; Smith, RP, 2007) |
| "To assess the prevalence of dysglycemia (hypoglycemia or hyperglycemia) associated with oral levofloxacin and gatifloxacin therapy in an outpatient setting, and to determine the characteristics of patients who developed dysglycemia while receiving either fluoroquinolone." | 3.74 | Prevalence of and risk factors for dysglycemia in patients receiving gatifloxacin and levofloxacin in an outpatient setting. ( LaPlante, KL; Mersfelder, TL; Quilliam, BJ; Ward, KE, 2008) |
| "Gatifloxacin, until recently one of the most commonly prescribed antibiotics, has been shown to produce hypoglycemia." | 3.74 | Gatifloxacin produces both hypoglycemia and hyperglycemia: a retrospective study. ( Brown, R; Haerian, H; McHugh, P; Solomon, SS; Somes, G, 2008) |
| "A retrospective cohort study of hospitalized adult (> or =18 years) patients admitted with Community Acquired Pneumonia (CAP) or Acute Exacerbation of Chronic Bronchitis (AECB) in a US tertiary care hospital between 7/1/01 and 12/31/04 treated with gatifloxacin or ceftriaxone during hospital admission." | 3.74 | An evaluation of the effects of gatifloxacin on glucose homeostasis. ( Hatton, RC; Onyenwenyi, AJ; Winterstein, AG, 2008) |
| "We present the histories, clinical findings, and hospital course of three patients who developed hypoglycemia after receiving gatifloxacin." | 3.73 | Hypoglycemia associated with the use of gatifloxacin. ( Arce, FC; Bhasin, R; Pasmantier, R, 2005) |
| " In the first, case patients were persons treated in the hospital for hypoglycemia after outpatient treatment with a macrolide, a second-generation cephalosporin, or a respiratory fluoroquinolone (gatifloxacin, levofloxacin, moxifloxacin, or ciprofloxacin)." | 3.73 | Outpatient gatifloxacin therapy and dysglycemia in older adults. ( Dresser, L; Juurlink, DN; Kopp, A; Low, DE; Mamdani, MM; Park-Wyllie, LY; Shah, BR; Stukel, TA; Stumpo, C, 2006) |
| "Gatifloxacin, a commonly prescribed antimicrobial can produce profound hypoglycemia and disturbances in glucose homeostasis especially in diabetes patients on sulphonylureas." | 3.73 | Gatifloxacin induced abnormalities in glucose homeostasis in a patient on glimepiride. ( Kesavadev, J; Rasheed, SA, 2006) |
| "A case of Gatifloxacin-induced severe and recurrent hypoglycemia in 62-year-old type 2 diabetic patient is presented." | 3.73 | Gatifloxacin-induced severe hypoglycemia in a patient with type 2 diabetes mellitus. ( Talwalkar, PG, 2006) |
| "Severe and resistant hypoglycemia occurred in two patients with diabetes mellitus who were receiving concomitant gatifloxacin and glyburide." | 3.72 | Severe and resistant hypoglycemia associated with concomitant gatifloxacin and glyburide therapy. ( Bélanger, C; Cossette, P; LeBlanc, M, 2004) |
| "To report a case of hypoglycemia in a patient receiving gatifloxacin for presumed exacerbation of chronic obstructive pulmonary disease (COPD)." | 3.71 | Possible gatifloxacin-induced hypoglycemia. ( Baker, SE; Hangii, MC, 2002) |
| " In contrast, hyperglycemia without QT/QTc prolongations was noted 24 h after dosing in one animal." | 1.48 | Usefulness of simultaneous and sequential monitoring of glucose level and electrocardiogram in monkeys treated with gatifloxacin under conscious and nonrestricted conditions. ( Chiba, K; Ishizaka, T; Mori, K; Yoshimatsu, Y, 2018) |
| "Gatifloxacin was found to be the probable cause in the majority of cases." | 1.33 | Gatifloxacin-induced dysglycemia. ( Zvonar, R, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 29 (87.88) | 29.6817 |
| 2010's | 4 (12.12) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yoshimatsu, Y | 1 |
| Ishizaka, T | 1 |
| Chiba, K | 1 |
| Mori, K | 1 |
| Nagai, M | 1 |
| Nagata, S | 1 |
| Yamagishi, N | 1 |
| Satoh, H | 1 |
| Furuhama, K | 1 |
| Ishiwata, Y | 1 |
| Yasuhara, M | 1 |
| Vinh, H | 1 |
| Anh, VT | 1 |
| Anh, ND | 1 |
| Campbell, JI | 1 |
| Hoang, NV | 1 |
| Nga, TV | 1 |
| Nhu, NT | 1 |
| Minh, PV | 1 |
| Thuy, CT | 1 |
| Duy, PT | 1 |
| Phuong, le T | 1 |
| Loan, HT | 1 |
| Chinh, MT | 1 |
| Thao, NT | 1 |
| Tham, NT | 1 |
| Mong, BL | 1 |
| Bay, PV | 1 |
| Day, JN | 1 |
| Dolecek, C | 1 |
| Lan, NP | 1 |
| Diep, TS | 1 |
| Farrar, JJ | 1 |
| Chau, NV | 1 |
| Wolbers, M | 1 |
| Baker, S | 1 |
| Menzies, DJ | 1 |
| Dorsainvil, PA | 1 |
| Cunha, BA | 1 |
| Johnson, DH | 1 |
| Baker, SE | 1 |
| Hangii, MC | 1 |
| LeBlanc, M | 1 |
| Bélanger, C | 1 |
| Cossette, P | 1 |
| Khovidhunkit, W | 1 |
| Sunthornyothin, S | 1 |
| Greenberg, AL | 1 |
| Decerbo, M | 1 |
| Fan, J | 1 |
| Brogan, SE | 1 |
| Cahalan, MK | 1 |
| Graumlich, JF | 1 |
| Habis, S | 1 |
| Avelino, RR | 1 |
| Salverson, SM | 1 |
| Gaddamanugu, M | 1 |
| Jamma, K | 1 |
| Aldag, JC | 1 |
| Mohr, JF | 2 |
| McKinnon, PS | 1 |
| Peymann, PJ | 1 |
| Kenton, I | 1 |
| Septimus, E | 1 |
| Okhuysen, PC | 1 |
| Bhasin, R | 1 |
| Arce, FC | 1 |
| Pasmantier, R | 1 |
| Bushardt, RL | 1 |
| Tailor, SA | 1 |
| Simor, AE | 1 |
| Cornish, W | 1 |
| Phillips, EJ | 1 |
| Knowles, S | 1 |
| Rachlis, A | 1 |
| Park-Wyllie, LY | 2 |
| Juurlink, DN | 2 |
| Kopp, A | 1 |
| Shah, BR | 1 |
| Stukel, TA | 1 |
| Stumpo, C | 1 |
| Dresser, L | 1 |
| Low, DE | 1 |
| Mamdani, MM | 1 |
| Gurwitz, JH | 1 |
| Kendall, C | 1 |
| Wooltorton, E | 1 |
| Hori, S | 1 |
| Kizu, J | 1 |
| Kawamura, M | 1 |
| Ittner, KP | 1 |
| Yadav, V | 1 |
| Deopujari, K | 1 |
| Smith, C | 1 |
| Zvonar, R | 1 |
| Catero, M | 1 |
| Kesavadev, J | 1 |
| Rasheed, SA | 1 |
| Talwalkar, PG | 1 |
| Lodise, T | 1 |
| Graves, J | 1 |
| Miller, C | 1 |
| Lomaestro, B | 1 |
| Smith, RP | 1 |
| Kapral, MK | 1 |
| LaPlante, KL | 1 |
| Mersfelder, TL | 1 |
| Ward, KE | 1 |
| Quilliam, BJ | 1 |
| Ali, T | 1 |
| Greenfield, RA | 1 |
| Scofield, H | 1 |
| Bronze, MS | 1 |
| Haerian, H | 1 |
| McHugh, P | 1 |
| Brown, R | 1 |
| Somes, G | 1 |
| Solomon, SS | 1 |
| Onyenwenyi, AJ | 1 |
| Winterstein, AG | 1 |
| Hatton, RC | 1 |
| Singh, N | 1 |
| Jacob, JJ | 1 |
1 review available for gatifloxacin and Fasting Hypoglycemia
| Article | Year |
|---|---|
Dysglycemia and fluoroquinolones: are you putting patients at risk?
Topics: Adolescent; Adult; Aza Compounds; Bacterial Infections; Blood Glucose; Ciprofloxacin; Dose-Response | 2007 |
1 trial available for gatifloxacin and Fasting Hypoglycemia
| Article | Year |
|---|---|
A multi-center randomized trial to assess the efficacy of gatifloxacin versus ciprofloxacin for the treatment of shigellosis in Vietnamese children.
Topics: Anti-Bacterial Agents; Child, Preschool; Ciprofloxacin; Dysentery, Bacillary; Feces; Female; Fluoroq | 2011 |
31 other studies available for gatifloxacin and Fasting Hypoglycemia
| Article | Year |
|---|---|
Usefulness of simultaneous and sequential monitoring of glucose level and electrocardiogram in monkeys treated with gatifloxacin under conscious and nonrestricted conditions.
Topics: Administration, Oral; Animals; Blood Glucose; Consciousness; Dose-Response Relationship, Drug; Elect | 2018 |
Clinicopathological aspect of dysglycemia in naive and diabetic rats induced by the fluoroquinolone antibacterial gatifloxacin.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Blood Glucose; Diabetes Mellitus, Experimental | 2010 |
Gatifloxacin-induced histamine release and hyperglycemia in rats.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Blood Glucose; Diabetes Mellitus, Experimental | 2010 |
Severe and persistent hypoglycemia due to gatifloxacin interaction with oral hypoglycemic agents.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Infective Agents; Bacterial Infections; Blood Gl | 2002 |
Possible gatifloxacin-induced hypoglycemia.
Topics: Aged; Anti-Infective Agents; Fluoroquinolones; Gatifloxacin; Humans; Hypoglycemia; Male; Pulmonary D | 2002 |
Severe and resistant hypoglycemia associated with concomitant gatifloxacin and glyburide therapy.
Topics: Aged; Aged, 80 and over; Drug Therapy, Combination; Female; Fluoroquinolones; Gatifloxacin; Glyburid | 2004 |
Hypoglycemia, hyperglycemia, and gatifloxacin.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Diabetes Mellitus, Type 2; Female; Fluoroquinolones; | 2004 |
Gatifloxacin therapy associated with hypoglycemia.
Topics: Aged; Anti-Bacterial Agents; Cohort Studies; Fluoroquinolones; Gatifloxacin; Humans; Hypoglycemia; P | 2005 |
Gatifloxacin as a possible cause of serious postoperative hypoglycemia.
Topics: Anti-Infective Agents; Blood Glucose; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Coronary | 2005 |
Hypoglycemia in inpatients after gatifloxacin or levofloxacin therapy: nested case-control study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Blood Glucose; Case-Control Studies; Female; | 2005 |
A retrospective, comparative evaluation of dysglycemias in hospitalized patients receiving gatifloxacin, levofloxacin, ciprofloxacin, or ceftriaxone.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Blood Glucose; Ceftriaxone; Ciprofloxacin; Fe | 2005 |
Hypoglycemia associated with the use of gatifloxacin.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Blood Glucose; Female; Fluoroquinolones; Gatifloxacin; Hum | 2005 |
Fluctuating blood glucose levels in an elderly diabetic patient.
Topics: Aged; Blood Glucose; Diabetes Mellitus; Dose-Response Relationship, Drug; Drug Interactions; Fluoroq | 2006 |
Glucose homeostasis abnormalities and gatifloxacin.
Topics: Aza Compounds; Fluoroquinolones; Gatifloxacin; Glucose; Homeostasis; Humans; Hyperglycemia; Hypoglyc | 2006 |
Outpatient gatifloxacin therapy and dysglycemia in older adults.
Topics: Aged; Aged, 80 and over; Ambulatory Care; Anti-Bacterial Agents; Case-Control Studies; Cephalosporin | 2006 |
Serious adverse drug effects--seeing the trees through the forest.
Topics: Anti-Bacterial Agents; Fluoroquinolones; Gatifloxacin; Humans; Hyperglycemia; Hypoglycemia | 2006 |
People with diabetes should avoid antibiotic gatifloxacin.
Topics: Bacterial Infections; Case-Control Studies; Contraindications; Diabetes Mellitus; Fluoroquinolones; | 2006 |
Effect of fluoroquinolones on plasma glucose levels in fasted and glucose-loaded mice.
Topics: Animals; Blood Glucose; Enoxacin; Fluoroquinolones; Gatifloxacin; Hypoglycemia; Male; Mice; Quinolon | 2006 |
Gatifloxacin and dysglycemia in older adults.
Topics: Anti-Bacterial Agents; Fluoroquinolones; Gatifloxacin; Humans; Hyperglycemia; Hypoglycemia | 2006 |
Gatifloxacin and dysglycemia in older adults.
Topics: Anti-Bacterial Agents; Fluoroquinolones; Gatifloxacin; Humans; Hyperglycemia; Hypoglycemia; Mortalit | 2006 |
Timely Tequin warning.
Topics: Blood Glucose; Contraindications; Fluoroquinolones; Gatifloxacin; Glucose Tolerance Test; Humans; Hy | 2006 |
Gatifloxacin-induced dysglycemia.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Female; Fluoroquinolones; Gatifloxacin; Humans; Hype | 2006 |
Gatifloxacin induced abnormalities in glucose homeostasis in a patient on glimepiride.
Topics: Anti-Infective Agents; Blood Glucose; Diabetes Mellitus; Female; Fluoroquinolones; Gatifloxacin; Hom | 2006 |
Gatifloxacin-induced severe hypoglycemia in a patient with type 2 diabetes mellitus.
Topics: Anti-Infective Agents; Blood Glucose; Diabetes Mellitus, Type 2; Fluoroquinolones; Gatifloxacin; Hum | 2006 |
Effects of gatifloxacin and levofloxacin on rates of hypoglycemia and hyperglycemia among elderly hospitalized patients.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Cohort Studies; Dose-Response Relationship, Drug; Fe | 2007 |
The effect of publication on Internet-based solicitation of personal-injury litigants.
Topics: Advertising; Aged; Anti-Infective Agents; Fluoroquinolones; Gatifloxacin; Humans; Hyperglycemia; Hyp | 2007 |
Prevalence of and risk factors for dysglycemia in patients receiving gatifloxacin and levofloxacin in an outpatient setting.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Creatinin | 2008 |
Gatifloxacin-associated hypoglycemia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Diabetes Mellitus, Type | 2007 |
Gatifloxacin produces both hypoglycemia and hyperglycemia: a retrospective study.
Topics: Aged; Anti-Bacterial Agents; Female; Fluoroquinolones; Gatifloxacin; Humans; Hyperglycemia; Hypoglyc | 2008 |
An evaluation of the effects of gatifloxacin on glucose homeostasis.
Topics: Adult; Aged; Anti-Bacterial Agents; Blood Glucose; Bronchitis; Ceftriaxone; Cohort Studies; Communit | 2008 |
Levofloxacin and hypoglycemia.
Topics: Clinical Competence; Fluoroquinolones; Gatifloxacin; Health Services Research; Hospitals, University | 2008 |